Session

PP 05 IBD (Posters)

PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN CELIAC DISEASE IN AN ALGERIAN POPULATION
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN CELIAC DISEASE IN AN ALGERIAN POPULATION

PP 05 IBD (Posters)  et al.

NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY BOWEL DISEASE – MORE QUESTIONS, TROUBLING ANSWERS
NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY BOWEL DISEASE – MORE QUESTIONS, TROUBLING ANSWERS

PP 05 IBD (Posters)  et al.

A LOW FAT, HIGH FIBER DIETARY INTERVENTION LEADS TO CHANGES IN SERUM PROTEOMIC PATTERNS IN CROHN’S DISEASE PATIENTS COMPARED TO HOUSEHOLD CONTROLS
A LOW FAT, HIGH FIBER DIETARY INTERVENTION LEADS TO CHANGES IN SERUM PROTEOMIC PATTERNS IN CROHN’S DISEASE PATIENTS COMPARED TO HOUSEHOLD CONTROLS

PP 05 IBD (Posters)  et al.

MICROBIAL SIGNATURE OF PATIENTS WITH NEWLY DIAGNOSED CROHN’S DISEASE IDENTIFIES PATIENTS WITH COMPLICATED DISEASE COURSE
MICROBIAL SIGNATURE OF PATIENTS WITH NEWLY DIAGNOSED CROHN’S DISEASE IDENTIFIES PATIENTS WITH COMPLICATED DISEASE COURSE

PP 05 IBD (Posters)  et al.

MALNUTRITION SCREENING IN A TERTIARY INFLAMMATORY BOWEL DISEASE OUTPATIENT CLINIC USING THE MUST TOOL
MALNUTRITION SCREENING IN A TERTIARY INFLAMMATORY BOWEL DISEASE OUTPATIENT CLINIC USING THE MUST TOOL

PP 05 IBD (Posters)  et al.

MONITORING ADHERENCE TO SUBCUTANEOUS BIOLOGICS IN IBD CARE USING DIGITAL TECHNOLOGY – A NHS DIGITAL & INNOVATION PROOF OF CONCEPT STUDY FOLLOWING COVID-19 IN THE UNITED KINGDOM
MONITORING ADHERENCE TO SUBCUTANEOUS BIOLOGICS IN IBD CARE USING DIGITAL TECHNOLOGY – A NHS DIGITAL & INNOVATION PROOF OF CONCEPT STUDY FOLLOWING COVID-19 IN THE UNITED KINGDOM

PP 05 IBD (Posters)  et al.

NOVEL DIGITAL HEALTH TOOLS IMPROVE CLINICAL OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS
NOVEL DIGITAL HEALTH TOOLS IMPROVE CLINICAL OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS

PP 05 IBD (Posters)  et al.

EFFECTIVENESS, SAFETY AND INCREMENTAL COSTS OF PROACTIVE THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN A REAL-LIFE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
EFFECTIVENESS, SAFETY AND INCREMENTAL COSTS OF PROACTIVE THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN A REAL-LIFE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

PP 05 IBD (Posters)  et al.

ELDERLY INFLAMMATORY BOWEL DISEASE IN A TUNISIAN POPULATION
ELDERLY INFLAMMATORY BOWEL DISEASE IN A TUNISIAN POPULATION

PP 05 IBD (Posters)  et al.

CORRELATION BETWEEN SERUM ANTI-TNF TROUGH CONCENTRATIONS AND TRANSMURAL DAMAGE IN CROHN’S DISEASE PATIENTS IN LONG STANDING AND STABLE CLINICAL REMISSION
CORRELATION BETWEEN SERUM ANTI-TNF TROUGH CONCENTRATIONS AND TRANSMURAL DAMAGE IN CROHN’S DISEASE PATIENTS IN LONG STANDING AND STABLE CLINICAL REMISSION

PP 05 IBD (Posters)  et al.

THE NLRP3 INFLAMMASOME IS UPREGULATED ON MRNA EXPRESSION LEVEL AND ACTIVATED ON PROTEIN LEVEL IN INFLAMMATORY BOWEL DISEASE PATIENTS IN A SYSTEMATIC META-ANALYSIS AND IN A NEW OBSERVATIONAL STUDY COHORT
THE NLRP3 INFLAMMASOME IS UPREGULATED ON MRNA EXPRESSION LEVEL AND ACTIVATED ON PROTEIN LEVEL IN INFLAMMATORY BOWEL DISEASE PATIENTS IN A SYSTEMATIC META-ANALYSIS AND IN A NEW OBSERVATIONAL STUDY COHORT

PP 05 IBD (Posters)  et al.

MANAGEMENT OF METASTATIC CUTANEOUS CROHN´S DISEASE USING USTEKINUMAB: A SINGLE CENTRE STUDY
MANAGEMENT OF METASTATIC CUTANEOUS CROHN´S DISEASE USING USTEKINUMAB: A SINGLE CENTRE STUDY

PP 05 IBD (Posters)  et al.

ULCERATIVE COLITIS – CROHN´S DISEASE CONVERSION RATE IN THE COHORT OF PATIENTS WITH ULCERATIVE COLITIS UNDERGOING COLECTOMY
ULCERATIVE COLITIS – CROHN´S DISEASE CONVERSION RATE IN THE COHORT OF PATIENTS WITH ULCERATIVE COLITIS UNDERGOING COLECTOMY

PP 05 IBD (Posters)  et al.

MAINTENANCE OF CLINICAL BIOCHEMICAL AND TRANSMURAL REMISSION IN IBD PATIENTS SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB
MAINTENANCE OF CLINICAL BIOCHEMICAL AND TRANSMURAL REMISSION IN IBD PATIENTS SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB

PP 05 IBD (Posters)  et al.

IMPACT OF VITAMINS, PROBIOTICS, ANTIBIOTICS, AND THE HISTORY OF COVID-19 INFECTION ON THE GUT MICROBIOME IN ULCERATIVE COLITIS PATIENTS
IMPACT OF VITAMINS, PROBIOTICS, ANTIBIOTICS, AND THE HISTORY OF COVID-19 INFECTION ON THE GUT MICROBIOME IN ULCERATIVE COLITIS PATIENTS

PP 05 IBD (Posters)  et al.

ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY
ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY

PP 05 IBD (Posters)  et al.

ETS1 AND SENESCENCE ASSOCIATED SECRETORY PHENOTYPE INDUCTION IN HUMAN SMALL INTESTINAL FIBROBLASTS
ETS1 AND SENESCENCE ASSOCIATED SECRETORY PHENOTYPE INDUCTION IN HUMAN SMALL INTESTINAL FIBROBLASTS

PP 05 IBD (Posters)  et al.

SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB FORMULATION DETERMINES A REDUCTION OF ANTIDRUG ANTIBODY LEVELS
SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB FORMULATION DETERMINES A REDUCTION OF ANTIDRUG ANTIBODY LEVELS

PP 05 IBD (Posters)  et al.

THIOPURINES IN CROHN'S DISEASE: DO THEY STILL HAVE A PLACE AS MONOTHERAPY IN REAL LIFE?
THIOPURINES IN CROHN'S DISEASE: DO THEY STILL HAVE A PLACE AS MONOTHERAPY IN REAL LIFE?

PP 05 IBD (Posters)  et al.

ENDOSCOPIC BALLOON DILATATION ASSOCIATED WITH BIOLOGICAL THERAPY IN CROHN’S DISEASE STRICTURES: A SINGLE CENTER EXPERIENCE
ENDOSCOPIC BALLOON DILATATION ASSOCIATED WITH BIOLOGICAL THERAPY IN CROHN’S DISEASE STRICTURES: A SINGLE CENTER EXPERIENCE

PP 05 IBD (Posters)  et al.

Item 361 - 380 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
19
20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42